Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

NCT02050321 is registered in ClinicalTrials.gov with University of Arizona as lead sponsor.

NCT NCT02050321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02050321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma
Lead sponsor
University of Arizona
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2013
Completion date
July 31, 2015
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma